U.S. government will buy more of GlaxoSmithKline and Vir’s COVID antibody drug
November 17, 2021 at 06:13 AM EST
The Glaxo GSK and Vir VIR drug, sotrovimab, was granted emergency authorization by the Food and Drug Administration in May.
Photography by Christophe Tomatis